Operating income before deduction of amortization: Zoetis Inc (ZTS)

Graphic logo of zoetis.com (ZTS)

Zoetis Inc. (ZTS) stability relies on the willingness of pet owners to spend on treatment despite regulatory risks. The absolute cash result of operations demonstrates confident growth, where the 4037.55 level is the current figure. High margins are sustained by unique vaccine patents, while strategic partnerships with agritech startups and clinics strengthen the company's market position.

ZTS - Zoetis Inc. Operating profit EBITDA over the range 11/23/2025 - 11/12/2026

Zoetis (ZTS) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Market Chart Zoetis Corporation|ZTS - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Zoetis|ZTS - Real Price to Acquire Entire Company
- balance sheet equity data:
Accounting Value of a Share Zoetis|ZTS - Book Capitalization|Market Capitalization to Book Value zoetis.com|ZTS - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Equity Ratio Zoetis Inc.|ZTS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Zoetis Inc|ZTS - Company Total Debt|Debts to Net Assets Zoetis|ZTS - Company Long-Term Liabilities|Current Liabilities Zoetis|Intermediate Liquidity Ratio zoetis.com
- earnings and market ratios statistics:
ZTS - Company Net Income|Company Profit Forecast Zoetis Inc.|ZTS - Price to Earnings Ratio|Price to Expected Earnings Ratio zoetis.com|ZTS - PEG Multiple|Company Value to EBITDA Zoetis|ZTS - Operating profit before deduction of amortization|Earnings per share for the last four quarters Zoetis|ZTS - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months zoetis.com|ZTS - Net earnings per share growth this year|Net earnings per share change forecast for next year Zoetis Inc.
Fundamental company valuation:ZTS Zoetis Corporation
Flagship merchandise of Zoetis Corp

Zoetis Inc. (ZTS) is optimizing costs through vaccine production automation, thereby increasing overall business margins. This EBITDA chart reflects the net cash flow from product sales, excluding the impact of taxes and debt service. The steady growth of the line confirms the effectiveness of implementing machine learning in molecule screening. Analyzing this trend allows for the elimination of the risk of overpaying for stagnating assets. The indicator's positive trend justifies the issuer's long-term investment attractiveness.

Competitor analysis for Zoetis Inc.

Operating income before deduction of amortization Chewy.com (CHWY)|FRPT - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization central.com CENT|TRUP (Trupanion) - Operating profit before deduction of amortization|Petco Health and Wellness Company, Inc. - Income before deduction of interest, taxes and amortization|DOGZ (Dogness International Corp.) - Operating profit EBITDA|bark.co (BARK) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization PetMed Express, Inc. (PETS)|tiandihui.com - Operating profit before amortization|Operating profit EBITDA BQ (Boqii)|IVP - Operating profit before deduction of amortization|BTTR: Operating profit before deduction of amortization|Operating income before deduction of amortization Wag Walking PET|PETQ (PetIQ, Inc.) - Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization ZOM (Zomedica)